Cyclohexene oxide → (1S*,2R*)-2-[1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]cyclohexanol

HRID 337743노트

반응식

HRID 337743 반응식
[O:1]1[CH2:6][CH2:5][CH2:4][CH2:3][CH:2]1[N:7]1[CH:11]=[CH:10][CH:9]=[N:8]1.C([Li])CCC.[CH:17]12[O:23][CH:18]1[CH2:19][CH2:20][CH2:21][CH2:22]2>C1COCC1>[O:1]1[CH2:6][CH2:5][CH2:4][CH2:3][CH:2]1[N:7]1[C:11]([C@H:17]2[CH2:22][CH2:21][CH2:20][CH2:19][C@@H:18]2[OH:23])=[CH:10][CH:9]=[N:8]1

참가 물질

5

반응물 3

HCID 9246Cyclohexene oxideHCID 218663101-(2-Tetrahydropyranyl)-1H-pyrazoleHCID 178418339Butyllithium

생성물 1

HCID 89962913(1S*,2R*)-2-[1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl]cyclohexanol수율 3%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

The reaction and aftertreatment were conducted in the same manner as in Example 8a by using 1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole (5.50 g, 36.1 mmol), n-butyl lithium (1.63 M solution in hexane; 24 mL, 39.1 mmol), cyclohexene oxide (3.80 g, 38.7 mmol) and THF (100 mL), to yield the title compound (270 mg, 3.0%) in the form of a diastereomeric mixture as a colorless oil.

후처리

  1. customThe reaction and aftertreatment

출처 및 근거

ORD 기록
ord-6a4053ec17394acf995cf8e4ea186825
출처 데이터셋
uspto-grants-2014_11
특허 번호
US08889741B2

반응 노트

불러오는 중…